Larson Tina Marriott's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Nov 22, 2021
- Accession no.
- 0001209191-21-066261
- Filed
- Nov 22, 2021
- Trade date
- Nov 18, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $47.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Larson Tina MarriottCIK 0001856414 | Officer (President and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 | Class A Common Stock | SSaleDisposed | −1,798 | $18.81 | −$33,820.38 | 50,702 | Direct | |
| Nov 18, 2021 | Class A Common Stock | SSaleDisposed | −702 | $19.20 | −$13,478.4 | 50,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.